The corporate, to be referred to as VitaTech, would leverage public funding to license longevity applied sciences developed in U.S. universities and help their continued growth. The funds would come from analysis foundations and authorities grants such because the Small Enterprise Innovation Analysis (SBIR) and Small Enterprise Expertise Switch (STTR).
Pfizer-Backed VitaDAO Votes on Creating For-Revenue Firm to Fund Longevity Analysis
previous post